Gene Expression Analysis Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Reagents & Consumables, Instruments, Service); By Application; By End User; By Region; Segment Forecast, 2024 - 2032
- Published Date:Mar-2024
- Pages: 119
- Format: PDF
- Report ID: PM4758
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
Gene Expression Analysis Market size was valued at USD 3.73 billion in 2023. The market is anticipated to grow from USD 4.02 billion in 2024 to USD 7.32 billion by 2032, exhibiting the CAGR of 7.8% during the forecast period
Industry Trends
Gene expression analysis is the study of the transcription and translation of genes into proteins, which are the building blocks of cells. It involves measuring the activity or abundance of specific genes at different times or under different conditions, such as during development, disease progression, or in response to environmental stimuli.
The global gene expression analysis market is driven by increasing demand for personalized medicine, growth in the biotechnology and biopharmaceutical industries, and technological advancements in genomics and proteomics. The market is also fueled by the increasing prevalence of cancer and other genetic disorders, which has led to a rising need for effective diagnostic tools. The market is witnessing a major shift towards next-generation sequencing (NGS) technologies. These technologies have transformed genomics by enabling the simultaneous analysis of millions of DNA sequences in a single run, making it faster and more cost-effective than traditional methods. This has led to an increased adoption of NGS technologies in research and clinical settings, driving the growth of the gene expression analysis market.
To Understand More About this Research: Request a Free Sample Report
Precision medicine is another major trend in the market, which involves tailoring medical treatments to individual patients based on their unique genetic profiles. Gene expression analysis plays a crucial role in this field, as it allows for the identification of specific genetic markers associated with certain diseases or conditions. This information can then be used to develop targeted therapies that are more effective and have fewer side effects than traditional treatments.
One of the major challenges in the market is the high cost of gene expression analysis techniques, especially Next-Generation Sequencing (NGS) technologies. These expenses can be a significant hindrance for researchers and clinicians, preventing them from accessing the powerful tools of gene expression analysis. Although the gene expression analysis market faces certain challenges, such as the complexity of data analysis and interpretation, the outlook for the market remains optimistic. The market is projected to maintain a robust growth rate, primarily due to the expanding need for personalized medicine and the continuous advancement of novel and innovative technologies.
Key Takeaways
- North America dominated the market and contributed over 40% market share of the gene expression analysis market size in 2023
- By product & service category, the reagents & consumables segment dominated the global gene expression analysis market size in 2023
- By application category, the drug discovery & development segment is projected to grow with a significant CAGR over the gene expression analysis market forecast period
What are the market drivers driving the demand for market?
Growth in biotechnology and biopharmaceutical industries drives gene expression analysis market growth.
The biotechnology and biopharmaceutical industries have contributed significantly to the growth of the market. With the development of new treatments and therapies, there is an increasing need for effective methods to analyze and understand gene expression patterns. Gene expression analysis allows researchers to study the activity of specific genes and their role in various diseases and conditions. This helps identify potential drug targets and develop personalized medicine approaches. The recent advancements in sequencing technologies have made it possible to analyze genomic data at a large scale, which has further fueled the demand for gene expression analysis tools and services. The growing focus on precision medicine and the development of novel therapeutics has created a robust market for gene expression analysis, with opportunities for both established players and emerging start-ups.
Which factor is restraining the demand for market?
The high cost of instruments and reagents is hindering the gene expression analysis market growth.
The cost of next-generation sequencing (NGS) platforms, which are widely used for gene expression analysis, is expensive for many researchers and institutions. Also, the cost of reagents and consumables required for library preparation, sequencing, and data analysis is substantial. These costs limit access to gene expression analysis techniques, particularly for researchers in academia. This slows down the pace of research and hinders the adoption of new technologies, thereby hindering the growth of the gene expression analysis market. Similarly, the high cost of instruments and reagents makes it difficult for researchers to conduct large-scale studies or to repeat experiments, which limits the reproducibility and reliability of results. This negatively impacts the overall progress of gene expression analysis research and its translation into clinical applications.
Report Segmentation
The market is primarily segmented based on product & service, application, end user, and region.
|
By Product & Service |
By Application |
By End User |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
Category Wise Insights
By Product & Service Insights
Based on product & service category analysis, the market has been segmented on the basis of reagents & consumables, instruments, and services. The reagents and consumables segment held the major share of the global market in 2023. This is mainly because reagents and consumables are essential components of various gene expression analysis techniques like PCR, microarray analysis, and next-generation sequencing. The analysis process requires specific reagents and consumables, such as primers, probes, enzymes, and nucleotides, which are repeatedly used. With the advancements in technology, specialized reagents and consumables have been developed that improve the sensitivity, specificity, and efficiency of gene expression analysis, further driving their demand.
The high cost of these reagents and consumables, specifically for advanced technologies like next-generation sequencing, also contributes to their substantial share in the market. The widespread usage of gene expression analysis in various fields, including basic research, drug discovery, and diagnostics, has stimulated a steady demand for reagents and consumables, ensuring their continued dominance in the market.
By Application Insights
Based on application category analysis, the market has been segmented on the basis of drug discovery & development, clinical diagnostics, and others. The drug discovery and development sector is on the verge of experiencing a significant boost in growth owing to the upsurge in chronic diseases like cancer, diabetes, and cardiovascular disorders, which has created a need for novel and efficacious drugs to combat these ailments. Also, advancements in technologies such as genomics, proteomics, and artificial intelligence have facilitated researchers to comprehend disease mechanisms better, thereby identifying probable drug targets and leading to the emergence of more personalized and targeted therapies.
Governments and private investors are increasingly investing in drug discovery and development research, providing funding for research initiatives and start-ups working in this space. Similarly, outsourcing drug discovery and development processes to contract research organizations (CROs) has also contributed to the growth of this market, as pharmaceutical companies seek external partners to help reduce costs and accelerate the development process.
Regional Insights
North America
In 2023, the North American region emerged as the dominant region in the global gene expression analysis market. The region's dominance is attributed to its advanced technological infrastructure, massive investments in research and development, and a flourishing biotechnology sector. North America is home to a thriving ecosystem of biotech firms, academic institutions, and research organizations that actively contribute to advancements in gene expression analysis. Also, the region's regulatory environment is very favorable, and the strong partnerships between academia and industry have fostered an environment conducive to innovation.
Asia Pacific
The Asia Pacific region is poised for substantial growth in the global gene expression analysis market over the forecast period due to the region's burgeoning interest in genomics research and personalized medicine, prompting increased investments in biotechnology and life sciences. Rapid economic development, particularly in countries like China and India, has led to expanded research infrastructure. As a result, the Asia Pacific region is becoming a focal point for gene expression analysis, with a rising number of collaborations, partnerships, and initiatives driving innovation and contributing to the region's anticipated substantial growth in this dynamic and evolving market.
Competitive Landscape
The competitive landscape of the market is characterized by intense competition and a dynamic interplay of key industry players striving for market dominance. The industry leaders are often engaged in strategic collaborations, acquisitions, and product launches to maintain their competitive edge. Simultaneously, a wave of innovative startups and emerging players are contributing to the competitive landscape by introducing novel technologies and niche solutions, fostering a climate of constant evolution.
Some of the major players operating in the global market include:
- Agilent Technologies, Inc
- BGI
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- LGC Biosearch Technologies
- Oxford Nanopore Technologies plc
- PacBio
- Promega Corporation
- QIAGEN
- Standard BioTools
- Thermo Fisher Scientific Inc.
Recent Developments
- In June 2023, Tempus, a company in the field of artificial intelligence and precision medicine, launched its standalone RNA next-generation sequencing assay, Tempus xR.
- In May 2023, Twist Bioscience Corporation introduced a comprehensive range of RNA sequencing tools, comprising the Twist RNA Library Prep Kit, Twist RNA Exome, and the Twist Ribosomal RNA & Hemoglobin Depletion Kit. These tools also include customizable target enrichment capabilities for RNA and whole transcriptome sequencing.
- In November 2023, Lexogen, a company in the genomics and transcriptomics field, announced the launch of its latest LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit. This revolutionary innovation has set new benchmarks in the realm of single-cell RNA sequencing.
Report Coverage
The gene expression analysis market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, product & service, application, end user, and their futuristic growth opportunities.
Gene Expression Analysis Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2023 |
USD 3.73 billion |
|
Revenue forecast in 2032 |
USD 7.32 billion |
|
CAGR |
7.8% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
By Product & Service, By Application, By End User, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
FAQ's
The global gene expression analysis market size is expected to reach USD 7.32 Billion by 2032
Key players in the market are Agilent Technologies, Inc, BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Illumina, Inc
North American contribute notably towards the global Gene Expression Analysis Market
Gene Expression Analysis Market exhibiting the CAGR of 7.8% during the forecast period
The Gene Expression Analysis Market report covering key segments are product & service, application, end user, and region.
